ER AGGREGATED HBV S PROMOTER DELETION WERE HCC TUMOR SPECIFIC

被引：0
|
作者：
Jiang, S. [1 ]
Zheng, J. [2 ]
Zhang, T. [2 ]
Chen, X. [2 ]
Lu, F. [2 ]
Zhuang, H. [2 ]
机构：
[1] So Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
976
引用
收藏
页码：S388 / S389
页数：2
相关论文
共 17 条
  • [1] Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China
    Li, Guo-Jian
    Harrison, Tim J.
    Yang, Jin-Ye
    Chen, Qin-Yan
    Wang, Xue-Yan
    Fang, Zhong-Liao
    LIVER INTERNATIONAL, 2013, 33 (06) : 936 - 943
  • [2] Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
    You, Maojun
    Gao, Yanan
    Fu, Junliang
    Xie, Runze
    Zhu, Zhenyu
    Hong, Zhixian
    Meng, Lingzhan
    Du, Shunda
    Liu, Junliang
    Wang, Fu-Sheng
    Yang, Pengyuan
    Chen, Liang
    HEPATOLOGY, 2023, 78 (03) : 943 - 958
  • [3] THE HBV PRES/S TRANSACTIVATOR REQUIRES DELETION OF THE CARBOXYTERMINUS AND PRESENCE OF THE ER SIGNAL-I FOR ACTIVITY
    LAUER, U
    KEKULE, AS
    MEYER, M
    CASELMANN, WH
    KOSHY, R
    HOFSCHNEIDER, PH
    HEPATOLOGY, 1990, 12 (04) : 880 - 880
  • [4] S-PHASE-SPECIFIC REGULATION BY DELETION MUTANTS OF THE HUMAN THYMIDINE KINASE PROMOTER
    LIPSON, KE
    CHEN, ST
    KONIECKI, J
    KU, DH
    BASERGA, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 6848 - 6852
  • [5] INFECTED HEPATOCYTE CLEARANCE AND SUSTAINED TUMOR REGRESSION BY HBSAG-SPECIFIC TCR-T THERAPY FOR HBV-RELATED HCC
    Du, S.
    Wisskirchen, K.
    Wan, X.
    Wu, X.
    Liu, F.
    Wu, Y.
    Zhang, K.
    Protzer, U.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A6 - A6
  • [6] Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
    Liu, Lulu
    Liu, Junwei
    Li, Pan
    Luo, Jijun
    Qin, Rui
    Peng, Qiao
    Li, Bin
    Wei, Xuyong
    Wang, Tian
    Shi, Hongyu
    Wang, Ming-Da
    Li, Chao
    Fang, Weijia
    Chen, Wei
    Xu, Xiao
    Yang, Tian
    Yin, Weiwei
    Zeng, Xun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [7] Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
    Lulu Liu
    Junwei Liu
    Pan Li
    Jijun Luo
    Rui Qin
    Qiao Peng
    Bin Li
    Xuyong Wei
    Tian Wang
    Hongyu Shi
    Ming-Da Wang
    Chao Li
    Weijia Fang
    Wei Chen
    Xiao Xu
    Tian Yang
    Weiwei Yin
    Xun Zeng
    Journal of Experimental & Clinical Cancer Research, 42
  • [8] Adenovirus-mediated transfer of suicide gene under control of tumor-specific promoter provides an efficient and safe vector for gene therapy of hepatocellular carcinoma (HCC)
    Gomar, C
    Genove, G
    Bilbao, R
    Peng, D
    Sangro, B
    Qian, C
    Prieto, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 223 - 223
  • [9] scRNA-seq reveals CK19+cancer stem cells and their specific SPP1+tumor-associated macrophage niche in HBV-related HCC
    Yang, Cheng L.
    Song, Rui
    Hu, Jun W.
    Huang, Jun T.
    Qi, Lu N.
    Wang, Qiu Y.
    Xiang, Bangde
    CANCER SCIENCE, 2024, 115 : 1497 - 1497
  • [10] INFECTED HEPATOCYTE CLEARANCE AND SUSTAINED TUMOR REGRESSION BY FIRST-IN-CLASS HBSAG-SPECIFIC TCR-T (SCG101) THERAPY FOR HBV-RELATED HCC
    Du, S.
    Wan, X.
    Wu, X.
    Wisskirchen, K.
    Zhang, K.
    Protzer, U.
    CYTOTHERAPY, 2023, 25 (06) : E12 - E12
12